Wechselwirkungen · Adenuric
ADENURIC 120 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 21
HOS-117833 · Präparat HOS-094697
Drug interaction studies of febuxostat with other cytotoxic chemotherapy have not been conducted. In the Tumor Lysis Syndrome pivotal trial febuxostat 120 mg daily was administered to patients undergoing several chemotherapy regimens, including monoclonal antibodies. However, drug-drug and drug-disease interactions were not explored during this study. Therefore, possible interactions with any concomitantly administered cytotoxic drug cannot be ruled out.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-09-13T17:33:00Z · SHA-256 bf3b2bc0a390a814c85817865bc1177e30eaf28768f0e6fde0b35bbfb17939a0 · Passage 2a5ea4e9435ceb031fa187cee94b460d83cc994f8d2434cd35430fc20918824c · Zeichen 796–1254 im Abschnitt